The new fast, effective and safe system for environmental biodecontamination, guaranteed by pharmaceutical quality
The Coronavirus emergency has imposed companies new rules and instructions to prevent any risk of contagion and to ensure employees work in a safe and protected environment.
In order to do this AM Instruments reccomends programming interventions which aim to completely disinfect environments and surfaces, thus guaranteeing safe working spaces.
In “Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing”, June 2020, FDA offers a guidance representing the current thinking of the Food and Drug Administration (FDA or Agency) on this topic.
The document focus on manufacturing controls to prevent contamination of drug, and, specifically suggests, to help prevent transmission among employees and contamination of drugs/materials by a COVID-19-infected employee engaged in drug manufacturing at the workplace, drug manufacturers should:
If a potential or actual viral contamination event is identified, drug manufacturers should promptly clean, disinfect, sanitize, and if necessary, sterilize affected equipment, surfaces, production areas, and facilities, before resuming manufacturing.
To learn more about Zherox b-pack, click here.